Related references
Note: Only part of the references are listed.A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy
Peng Zhao et al.
BLOOD ADVANCES (2021)
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab
Sonata Jodele et al.
BLOOD (2020)
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy
Narendranath Epperla et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation
Cihan Heybeli et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT
Reem Elfeky et al.
BLOOD ADVANCES (2020)
Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort
Michelle Schoettler et al.
BLOOD ADVANCES (2020)
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT
Hiroyuki Matsui et al.
BLOOD ADVANCES (2020)
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease
Sarah Kraft et al.
BONE MARROW TRANSPLANTATION (2019)
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal
Ang Li et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Thrombotic microangiopathy following haematopoietic stem cell transplant
Eleanor G. Seaby et al.
PEDIATRIC NEPHROLOGY (2018)
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation
Merve Postalcioglu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Acute graft-versus-host disease of the gut: considerations for the gastroenterologist
Steven Naymagon et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Transplant-associated thrombotic microangiopathy: opening Pandora's box
E. Gavriilaki et al.
BONE MARROW TRANSPLANTATION (2017)
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults
Monica Konar et al.
BLOOD (2017)
The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy
Sonata Jodele et al.
BLOOD (2016)
Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy
S. Vasu et al.
BONE MARROW TRANSPLANTATION (2016)
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
Uday Popat et al.
BLOOD (2015)
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Sonata Jodele et al.
BLOOD REVIEWS (2015)
Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant
Sudhanshu Mulay et al.
JOURNAL OF CLINICAL APHERESIS (2015)
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Sonata Jodele et al.
BLOOD (2014)
Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy
Sonata Jodele et al.
BLOOD (2013)
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy
Regis Peffault de Latour et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
Sonata Jodele et al.
TRANSFUSION (2013)
DOES EARLY INITIATION OF THERAPEUTIC PLASMA EXCHANGE AFFECT OUTCOME IN PEDIATRIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY?
S. Jodele et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Benjamin L. Laskin et al.
BLOOD (2011)
Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange
G. A. Kennedy et al.
BONE MARROW TRANSPLANTATION (2010)
Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation
Byung-Sik Cho et al.
TRANSPLANTATION (2010)
Vascular endothelium and graft-versus-host disease
Barbara C. Biedermann
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: An autopsy study
Koushan Siami et al.
TRANSPLANTATION (2008)
Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
E. D. Batts et al.
BONE MARROW TRANSPLANTATION (2007)
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
Cornelio Uderzo et al.
TRANSPLANTATION (2006)
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome - III. An additional study of 57 consecutive patients, 2002-2005
MA Howard et al.
TRANSFUSION (2006)
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
MT Martinez et al.
BONE MARROW TRANSPLANTATION (2005)
Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation
VT Ho et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies
F Kroschinsky et al.
INTENSIVE CARE MEDICINE (2002)
Share Paper
